Slide background
INNOVATING targeting
Slide background
INNOVATING targeting


Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation ... Read all


Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress Read all


Philogen is a fully integrated company active in the discovery, GMP production and clinical development of targeted therapeutics. We have a leading position in the field of antibody-based therapeutics ... Read all


Philogen has finalized numerous collaborative agreements with large pharmaceutical companies. Read all

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

By continuing to browse or by closing this window, you accept the use of cookies.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. By closing this banner or continuing to browse, you agree to the use of cookies.

I Accept Cookie Policy